Hudson Bay Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-222,597
Closed -$48.3M 1266
2021
Q1
$48.3M Buy
222,597
+192,597
+642% +$36.2M 0.6% 21
2020
Q4
$3.46M Hold
30,000
0.04% 290
2020
Q3
$2.92M Buy
+30,000
New +$3.45M 0.04% 307
2020
Q2
Sell
-30,000
Closed -$2.63M 628
2020
Q1
$2.63M Buy
30,000
+5,000
+20% +$529K 0.07% 230
2019
Q4
$2.61M Buy
25,000
+20,000
+400% +$2.24M 0.06% 248
2019
Q3
$575K Buy
+5,000
New +$759K 0.02% 341
2018
Q2
Sell
-30,000
Closed -$3.38M 1029
2018
Q1
$3.38M Buy
+30,000
New +$3.77M 0.07% 320

Other funds holding GWPH

Hudson Bay Capital Management's GWPH Position: Q2 2021 in Review

Hudson Bay Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 222,597 shares — an estimated $48.3M sold.

Hudson Bay Capital Management first reported a position in GWPH in Q1 2018 and held it in 7 quarters. The position peaked at $48.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Hudson Bay Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Hudson Bay Capital Management sold 222,597 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $48.3M.
  • Hudson Bay Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 7 quarters.
  • Hudson Bay Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $48.3M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Hudson Bay Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.